Benazecare Flavour 20 mg Tablets for Dogs
Benazecare Flavour 20 mg Tablets for Dogs
Authorised
- Benazepril hydrochloride
Product identification
Medicine name:
Benazecare Flavour 20 mg Tablets for Dogs
Benazecare Flavour 20 mg tabletten voor honden
Benazecare Flavour 20 mg comprimés pour chiens
Benazecare Flavour 20 mg Tabletten für Hunde
Active substance:
- Benazepril hydrochloride
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Benazepril hydrochloride20.00milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QC09AA07
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- Aluminium/aluminium blister packs containing 14 tablets packed in a cardboard box with a package leaflet. Benazecare Flavour20 mg tablets are supplied in packs of 14 tablets
- Aluminium/aluminium blister packs containing 14 tablets packed in a cardboard box with a package leaflet. Benazecare Flavour20 mg tablets are supplied in packs of 28 tablets
- Aluminium/aluminium blister packs containing 14 tablets packed in a cardboard box with a package leaflet. Benazecare Flavour20 mg tablets are supplied in packs of 56 tablets
- Aluminium/aluminium blister packs containing 14 tablets packed in a cardboard box with a package leaflet. Benazecare Flavour20 mg tablets are supplied in packs of 140 tablets
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ecuphar
Marketing authorisation date:
Manufacturing sites for batch release:
- Lelypharma B.V.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V350725
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0452/002
Concerned member states:
-
Austria
-
Belgium
-
France
-
Germany
-
Luxembourg
-
Netherlands
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
How useful was this page?: